Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G F Fleming

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
The best of times...the worst of timesG F Fleming
Current Oncology Reports|December 21, 2000
Systemic therapy for advanced or recurrent endometrial carcinomaG F Fleming
Seminars in Oncology|December 1, 1992
Antifolates: the next generationG F Fleming, R L Schilsky
The Medical Journal of Australia|January 17, 1976
Letter: Granulocytopenia due to clindamycinG F Fleming, G R Crowe
Substance Use & Misuse|August 12, 2003
The separation of codeine from nonprescription combination analgesic productsG F Fleming, J C McElnay, C M Hughes
Drug Safety|December 12, 2001
Benefits and risks of self medicationC M Hughes, J C McElnay, G F Fleming
Clinical Breast Cancer|March 20, 2002
Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancerA R Hartman, G F Fleming, J J Dillon
American Journal of Clinical Oncology|March 10, 2001
Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxelG F Fleming, S E Waggoner, J Rotmensch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Megestrol acetate reverses multidrug resistance and interacts with P-glycoproteinG F Fleming, J M Amato, M Agresti, et al.
American Journal of Clinical Oncology|June 17, 2000
A phase I study of liposomal doxorubicin (Doxil) with topotecanC W Ryan, G F Fleming, L Janisch, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
The best of times...the worst of timesG F Fleming
Current Oncology Reports|December 21, 2000
Systemic therapy for advanced or recurrent endometrial carcinomaG F Fleming
Seminars in Oncology|December 1, 1992
Antifolates: the next generationG F Fleming, R L Schilsky
The Medical Journal of Australia|January 17, 1976
Letter: Granulocytopenia due to clindamycinG F Fleming, G R Crowe
Substance Use & Misuse|August 12, 2003
The separation of codeine from nonprescription combination analgesic productsG F Fleming, J C McElnay, C M Hughes
Drug Safety|December 12, 2001
Benefits and risks of self medicationC M Hughes, J C McElnay, G F Fleming
Clinical Breast Cancer|March 20, 2002
Meta-analysis of adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy in postmenopausal women with estrogen receptor-positive, node-positive breast cancerA R Hartman, G F Fleming, J J Dillon
American Journal of Clinical Oncology|March 10, 2001
Absence of major peripheral neuropathy in a phase II trial of ifosfamide with vinorelbine in patients with ovarian cancer previously treated with platinum and paclitaxelG F Fleming, S E Waggoner, J Rotmensch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Megestrol acetate reverses multidrug resistance and interacts with P-glycoproteinG F Fleming, J M Amato, M Agresti, et al.
American Journal of Clinical Oncology|June 17, 2000
A phase I study of liposomal doxorubicin (Doxil) with topotecanC W Ryan, G F Fleming, L Janisch, et al.
Pageof 6